tirzepatide vs semaglutide weight loss efficacy side effects Comparative safety and of and tirzepatide: Implications for clinical decision-making in obesity management tirzepatide semaglutide efficacy side effects – Tirzepatide caused roughly half as

The report documents two individuals who had taken 10 times their intended dosage

According to NICE Technology Appraisal 875 , semaglutide 2.4 mg (Wegovy) may be considered for adults with a BMI of at least 35 kg/m, or at least 30 kg/m with at least one weight-related comorbidity

Alterations in carbohydrate intake and meal timing may affect blood glucose control and medication requirements, particularly for those taking insulin or sulfonylureas

The doses may need to be increased to up to three times the recommended over-the-counter dosing

(1 unit equals 1 division on the doser) BPC157 Certificate of Analysis The COAs shown are representative examples